Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001451612-25-000014
Filing Date
2025-12-12
Accepted
2025-12-12 18:37:21
Documents
1
Period of Report
2025-12-10

Document Format Files

Seq Description Document Type Size
1 form4-12122025_111217.html 4  
1 form4-12122025_111217.xml 4 26399
  Complete submission text file 0001451612-25-000014.txt   27830
Mailing Address 890 WINTER STREET SUITE 320 WALTHAM MA 02451
Business Address
Booth Bruce (Reporting) CIK: 0001451612 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 251569508

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)